These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4837866)

  • 1. [Effect of treatment with nucleotides and asparagine on 35S-methionine metabolism in chronic liver disease].
    Fodor O; Iencica R; Szántay I
    Rev Roum Med Intern; 1974; 11(3):263-6. PubMed ID: 4837866
    [No Abstract]   [Full Text] [Related]  

  • 2. Some aspects of the metabolism of (35S) methionine in hyperlipemic subjects.
    Szantay I; Popescu TA; Cucuianu M
    Clin Chim Acta; 1971 Mar; 32(1):75-9. PubMed ID: 5096430
    [No Abstract]   [Full Text] [Related]  

  • 3. [The study of urinary metabolites of methionine in chronic hepatitis after administration of asparagine and acetyl-methionine].
    Szantay I; Cotul S
    Stud Cercet Med Interna; 1968; 9(1):35-42. PubMed ID: 5665104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Purine and orotic acid therapy of chronic hepatitis and liver cirrhosis].
    ROSSING P; EBERHARD H; BRANDENBURG W
    Dtsch Med J; 1956 Apr; 7(8):201-4. PubMed ID: 13344173
    [No Abstract]   [Full Text] [Related]  

  • 5. 35S-methionine metabolism and plasma level of catecholamines during surgical stress.
    Toader C; Acalovschi I; Szántay I
    Rev Roum Med Intern; 1974; 11(1):135-9. PubMed ID: 4407681
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of 35S-methionine metabolism in hepatic cirrhosis.
    Szantay J; Szirmai E; Cotul S
    Mater Med Pol; 1974; 6(2):120-2. PubMed ID: 4431243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism of S35 methionine in liver cirrhosis].
    Szantay I; Szirmai E; Cotul S
    Presse Med (1893); 1971 Feb; 79(9):399. PubMed ID: 5546800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of asparagine on hepatic physiopathological syndromes].
    Fodor O; Cotul S; Barbarino F; Grigoras D; Nicoară A; Suciu A
    Stud Cercet Med Interna; 1968; 9(5):405-14. PubMed ID: 5716055
    [No Abstract]   [Full Text] [Related]  

  • 10. [35S excretion in rats after injection of 35S methionine in relation to protein and amino acid nutrition].
    Krieghoff E; Bergner H
    Arch Tierernahr; 1976 Sep; 25(7):495-503. PubMed ID: 971096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo [35S]-methionine incorporation.
    Esposito AM; Kinzy TG
    Methods Enzymol; 2014; 536():55-64. PubMed ID: 24423266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some results of treatment of chronic hepatitis with potassium orotate (first preliminary report)].
    Brailski Kh; Kolarski V; Mendizova A
    Vutr Boles; 1972; 11(6):69-73. PubMed ID: 4680044
    [No Abstract]   [Full Text] [Related]  

  • 13. [The dynamics of 75Se-selenomethionine in blood and plasma in chronic hepatitis under action of the sodium salt of asparaginic acid].
    Fodor O; Szántay I; Cotul S
    Nucl Med (Stuttg); 1968 Aug; 7(2):130-6. PubMed ID: 5688424
    [No Abstract]   [Full Text] [Related]  

  • 14. The uptake of 35S into tissues after injection of (35S) methionine.
    GAITONDE MK; RICHTER D
    Biochem J; 1955 Apr; 59(4):690-6. PubMed ID: 14363165
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonenzymatic labeling of proteins by preparations of [35S]methionine.
    Suissa M
    Anal Biochem; 1981 Jul; 115(1):67-71. PubMed ID: 6458219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urinary elimination of purine and pyrimidine under the therapeutic influence of aspartic acid in chronic hepatitis].
    Iencica R; Suciu A
    Stud Cercet Med Interna; 1972; 13(1):63-70. PubMed ID: 5022327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of treatment with nucleotides and aspartic acid in chronic liver diseases].
    Iencica R
    Med Interna (Bucur); 1972 Dec; 24(12):1449-53. PubMed ID: 4655566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of diseases of liver parenchyma; experiences with intravenous injections of a preparation containing a mixture of orotic acid and purines].
    BECKMANN K; BRUGEL H; MERTZ DP
    Dtsch Med Wochenschr; 1956 Apr; 81(15):573-7. PubMed ID: 13317662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic progress in chronic liver diseases].
    Wildhirt E
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):207-8. PubMed ID: 4894834
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic labeling with amino acids.
    Bonifacino JS
    Curr Protoc Protein Sci; 2001 May; Chapter 3():Unit 3.7. PubMed ID: 18429172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.